| Metric | Q3 2021 | Q2 2021 | Q3 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $11.4B | $10.8B | $9.3B | 5.2% | 22.8% |
| Op. Income | $2.5B | $2.9B | $1.4B | -16.7% | 79.6% |
| Gross Margin | 99.0% | 102.6% | 88.0% | -3.6pp | 11.0pp |
| Net Margin | 16.0% | 21.1% | 11.6% | -5.0pp | 4.5pp |
| EPS (Diluted) | $2.27 | $2.80 | $1.30 | -18.9% | 74.6% |
| Free Cash Flow | $3.7B | $2.9B | $1.8B | 31.1% | 104.8% |
| Item | Amount |
|---|---|
| REVENUE | $11.4B |
| Cost of Revenue | $116M |
| GROSS PROFIT | $11.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $1.4B |
| General & Administrative | $1.5B |
| SG&A Expenses | $2.9B |
| Other Expenses | $5.9B |
| Operating Expenses | $8.8B |
| Cost & Expenses | $8.9B |
| OPERATING INCOME | $2.5B |
| Interest Income | $2.3B |
| Interest Expense | $307M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $2.5B |
| Income Tax Expense | $624M |
| Net Income from Continuing Ops | $1.8B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1.8B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.8B |
| D&A | $442M |
| EBIT | $2.5B |
| EBITDA | $2.9B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $11.4B |
| Cost of Revenue | $116M |
| GROSS PROFIT | $11.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $1.4B |
| General & Administrative | $1.5B |
| SG&A Expenses | $2.9B |
| Other Expenses | $5.9B |
| Operating Expenses | $8.8B |
| Cost & Expenses | $8.9B |
| OPERATING INCOME | $2.5B |
| Interest Income | $2.3B |
| Interest Expense | $307M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $2.5B |
| Income Tax Expense | $624M |
| Net Income from Continuing Ops | $1.8B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1.8B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.8B |
| D&A | $442M |
| EBIT | $2.5B |
| EBITDA | $2.9B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $1.8B |
| Depreciation & Amortization | $442M |
| Stock-Based Compensation | $73M |
| Deferred Income Tax | -$85M |
| Other Non-Cash Items | -$258M |
| Change in Working Capital | $2.2B |
| OPERATING CASH FLOW | $4.2B |
| Capital Expenditure | -$430M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$355M |
| Sales/Maturities of Investments | $3.1B |
| Other Investing Activities | -$3.5B |
| NET CASH FROM INVESTING | -$1.2B |
| Net Debt Issuance | -$2.4B |
| Common Stock Repurchased | -$3.3B |
| Common Dividends Paid | -$366M |
| Other Financing Activities | $166M |
| NET CASH FROM FINANCING | -$5.9B |
| FREE CASH FLOW | $3.7B |
| Net Change in Cash | -$2.9B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $27.5B |
| Short-Term Investments | $8.8B |
| Net Receivables | $48.7B |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $85.1B |
| PP&E (Net) | $5.0B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $129.3B |
| Tax Assets | $0 |
| Other Non-Current Assets | -$35.1B |
| TOTAL NON-CURRENT ASSETS | $99.2B |
| TOTAL ASSETS | $184.3B |
| Account Payables | $9.6B |
| Short-Term Debt | $2.3B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $84.3B |
| TOTAL CURRENT LIABILITIES | $96.2B |
| Long-Term Debt | $34.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $29.1B |
| TOTAL NON-CURRENT LIABILITIES | $63.6B |
| TOTAL LIABILITIES | $159.8B |
| Common Stock | $156M |
| Additional Paid-In Capital | $12.4B |
| Retained Earnings | $14.8B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$3.0B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $24.4B |
| Minority Interest | $0 |
| TOTAL EQUITY | $24.4B |
| TOTAL LIABILITIES & EQUITY | $184.3B |
| Total Debt | $36.7B |
| Net Debt | $9.2B |
